NDC 59467-700

Ryaltris

Olopatadine Hydrochloride And Mometasone Furoate

Ryaltris is a Nasal Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Hikma Specialty Usa Inc.. The primary component is Mometasone Furoate Monohydrate; Olopatadine Hydrochloride.

• Product ID: 59467-700_0dc5de3e-7539-4cf4-9356-ac2c537657b9
• NDC: 59467-700
• Product Type: Human Prescription Drug
• Proprietary Name: Ryaltris
• Generic Name: Olopatadine Hydrochloride And Mometasone Furoate
• Dosage Form: Spray, Metered
• Route of Administration: NASAL
• Marketing Start Date: 2022-08-15
• Marketing Category: NDA /
• Application Number: NDA211746
• Labeler Name: HIKMA SPECIALTY USA INC.
• Substance Name: MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE
• Active Ingredient Strength: 25 ug/1; ug/1
• Pharm Classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 59467-700-27

12 CARTON in 1 BOX (59467-700-27) > 1 BOTTLE, SPRAY in 1 CARTON > 240 SPRAY, METERED in 1 BOTTLE, SPRAY

• Marketing Start Date: 2022-08-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details